Xilio Therapeutics
(NASDAQ) XLO
Xilio Therapeutics Financials at a Glance
Market Cap
$49.21M
Revenue (TTM)
$43.77M
Net Income (TTM)
$35.04M
EPS (TTM)
$-5.56
P/E Ratio
-1.53
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$8.56
Volume
489
Open
$8.29
Price
$8.56
Volume
489
Open
$8.29
Previous Close
$8.56
Daily Range
$8.29 - $8.56
52-Week Range
$6.47 - $16.52
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$8.56
Volume
489
Open
$8.29
Previous Close
$8.56
Daily Range
$8.29 - $8.56
52-Week Range
$6.47 - $16.52
XLO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Xilio Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
76
CEO
René Russo, PharmD
Website
www.xiliotx.comHeadquarters
Waltham, MA 02451, US
XLO Financials
Key Financial Metrics (TTM)
Gross Margin
96%
Operating Margin
-96%
Net Income Margin
-80%
Return on Equity
-133%
Return on Capital
-43%
Return on Assets
-23%
Earnings Yield
-65.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$49.21M
Shares Outstanding
5.78M
Volume
489
Short Interest
0.00%
Avg. Volume
38.74K
Financials (TTM)
Gross Profit
$42.23M
Operating Income
$41.98M
EBITDA
$40.44M
Operating Cash Flow
$4.99M
Capital Expenditure
$518.00K
Free Cash Flow
$5.51M
Cash & ST Invst.
$137.53M
Total Debt
$6.95M
Xilio Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.69M
+693.9%
Gross Profit
$27.82M
+1513.4%
Gross Margin
2.03%
N/A
Market Cap
$49.21M
N/A
Market Cap/Employee
$768.89K
N/A
Employees
64
N/A
Net Income
$10.36M
+179.1%
EBITDA
$1.30M
+109.8%
Quarterly Fundamentals
Net Cash
$130.58M
+176.9%
Accounts Receivable
$5.00M
N/A
Inventory
$0.00
N/A
Long Term Debt
$5.61M
-19.3%
Short Term Debt
$1.34M
+13.0%
Return on Assets
-22.65%
N/A
Return on Invested Capital
-42.66%
N/A
Free Cash Flow
$2.09M
+85.2%
Operating Cash Flow
$2.00M
+85.9%